BLACU — Bellevue Life Sciences Acquisition Cashflow Statement
0.000.00%
Last trade - 00:00FinancialsMicro Cap
- $60.22m
- $60.21m
Annual cashflow statement for Bellevue Life Sciences Acquisition, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.024 | -0.003 | -0.035 | 0.404 |
| Non-Cash Items | — | — | — | -2.78 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0 | 0.003 | 0.031 | 1.55 |
| Change in Prepaid Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Taxes Payable | ||||
| Cash from Operating Activities | -0.024 | -0 | -0.004 | -0.819 |
| Other Investing Cash Flow Items | — | — | — | -33.8 |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | — | — | — | -33.8 |
| Financing Cash Flow Items | -0.239 | -0.157 | -0.676 | -1.39 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0.086 | -0.057 | 0.124 | 34.5 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.063 | -0.058 | 0.12 | -0.109 |